![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ingen Technologies Inc (CE) | USOTC:IGNT | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
The commercial can be seen on the OTC Video tab at: http://www.otcmarkets.com/stock/IGNT/video-and-presentations
The company has received large purchase orders from the Department of the Interior and the Department of Homeland Security in the past 90 days; an indication that the proprietary patented medical technology is of serious consideration for use with various government and commercial applications.
"The commercial was launched as part of our new marketing program to target the projected $50M annual sales for Ingen. There is serious interest in the acquisition of our medical division, and we are undecided on accepting an offer at this time. Our new Telecom Division has recently landed contracts with TATA Communications and China Unicom, two giants in the global telecom services industry. Our focus is on revenues, and our medical division has suddenly demonstrated great potential with the $8B Respiratory markets," stated Gary Tilden, Chairman.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
CONTACT: Gary Tilden 951-688-7840 www.ingen-tech.com info@ingen-tech.com www.useatmc.com
1 Year Ingen Technologies (CE) Chart |
1 Month Ingen Technologies (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions